The technique at the center of the study, CT-derived fractional flow reserve or CT-FFR, deserves a moment of explanation because it is doing the heavy scientific lifting here. Fractional flow reserve is classically measured with a pressure wire threaded into a coronary artery during invasive catheterization; it expresses the ratio of blood pressure distal to a stenosis to the pressure available in the aorta, with values below 0.80 generally signaling ischemia that warrants stenting. CT-FFR replicates this measurement computationally. Software ingests the geometry of the coronary tree extracted from a coronary CT angiogram, models the physics of blood flow through it, and estimates the pressure drop across each lesion without ever entering the patient’s body. That means researchers can, in principle, measure the functional significance of coronary narrowings repeatedly over time, at low risk and low cost, which is exactly what made the present longitudinal design feasible.

The investigators took a retrospective look at patients who had undergone TAVR for aortic stenosis and who also happened to have coronary CT angiography both before the procedure and at least six months afterward. That second scan is not routine practice; it was obtained on the basis of individualized clinical decisions, which introduces some selection considerations the authors acknowledge. From the available records, 62 patients made it into the final analysis, contributing 112 coronary arteries for paired evaluation. Every included patient had at least one coronary stenosis of moderate severity, in the 30 to 90 percent range, at baseline. The median interval between the pre-procedure scan and the follow-up scan was 363 days, so the team was effectively comparing the coronary circulation one year apart, straddling the valve replacement.

The headline finding is counterintuitive: after the aortic valve was fixed, CT-FFR values across the studied arteries went down, not up. Across all vessels, the mean CT-FFR fell from 0.84 before TAVR to 0.82 afterward, a small but highly statistically significant decline. When the arteries were analyzed by vessel, the pattern became more textured. The right coronary artery dropped from 0.89 to 0.83, and the left circumflex artery fell from 0.82 to 0.79, both statistically significant changes. The left anterior descending artery, the largest and most clinically scrutinized coronary vessel, showed no significant change, edging from 0.84 to 0.85. None of these post-TAVR values crossed the conventional 0.80 ischemic threshold on average, but the direction of travel was consistent enough to demand an explanation.

The obvious first suspect was plaque progression. If atherosclerosis had advanced during the follow-up year, the pressure drop across lesions would increase and FFR would fall. So the researchers systematically compared qualitative plaque features, such as the presence of low-attenuation cores, spotty calcium and the napkin-ring sign, along with quantitative metrics like plaque volume and stenosis percentage, between the baseline and follow-up scans. The result was a null finding of real scientific value: no significant differences emerged in any qualitative or quantitative plaque characteristic. The atherosclerotic burden, as seen by CT, was essentially frozen in place. And when the team formally tested the relationship, they found no correlation between changes in CT-FFR and changes in plaque measurements, effectively ruling out plaque dynamics as the driver of the hemodynamic shift.

That leaves hemodynamics itself, and here the study offers a compelling clue. The left ventricular mass index, a measure of the thickness and bulk of the heart’s main pumping chamber, decreased significantly after TAVR, confirming the well-documented phenomenon of reverse remodeling: once the pressure overload of aortic stenosis is relieved, the hypertrophied muscle begins to shrink back toward normal. Intriguingly, the magnitude of LV mass regression showed a trend toward correlation with the change in CT-FFR, with a correlation coefficient of -0.183 and a P value of 0.054, just shy of conventional significance. The authors interpret this as evidence that the falling FFR values primarily reflect improved hemodynamics secondary to relief of the valve obstruction and ventricular remodeling, rather than any worsening of the coronary lesions themselves.

The physiology behind that interpretation is worth unpacking. Fractional flow reserve is not a fixed property of a stenosis; it depends on the flow of blood racing through the narrowed segment during maximal hyperemia. When the aortic valve is replaced, downstream resistance falls, the ventricle generates pressure more efficiently, and coronary flow patterns change in complex ways. Microvascular function, which is often abnormal in aortic stenosis, also evolves during recovery. Any of these shifts can alter the pressure gradient across a coronary lesion independent of its anatomy. In other words, the same anatomical narrowing can be functionally different in a remodeled heart, and the study’s data suggest that is precisely what CT-FFR is capturing in these patients.

For clinicians, the implications cut in two directions. On one hand, the findings are reassuring: a modest post-TAVR decline in CT-FFR, in a stable patient, does not appear to signal aggressive plaque growth and may simply be a byproduct of a heart recalibrating to its new pressure environment. On the other hand, the results are a caution against interpreting serial CT-FFR values in TAVR patients the way one would in ordinary stable chest pain populations. The reference frame changes after valve replacement, and a drop of a few hundredths in FFR may carry a very different meaning in a ventricle that is actively unloading and remodeling. The authors are careful to note that their conclusions apply primarily to clinically stable patients, and that follow-up CT angiography in this cohort was performed on individualized clinical grounds rather than as a standardized protocol.

The study also carries honest limitations that shape how far its message travels. It was retrospective and observational, with a modest sample of 62 patients, and the decision to obtain post-TAVR CCTA was not uniform, raising the possibility of selection effects. The follow-up window, while a median of nearly a year, captures only one snapshot of what is likely a longer remodeling trajectory. Still, the core contribution stands: this is one of the clearest demonstrations that after TAVR, coronary functional measurements and coronary anatomy can decouple, with FFR drifting downward while plaque burden holds steady. As CT-FFR becomes more widely adopted and as TAVR expands to younger and lower-risk patients, understanding this post-procedural hemodynamic evolution will matter for deciding which lesions truly need stenting and which are simply adapting to a heart that has been set free. The Shenyang team’s data suggest that, at least in the first year after valve replacement, the arteries themselves are not the story; the recovering ventricle is.

Subject of Research: Changes in CT-derived coronary fractional flow reserve and plaque characteristics after transcatheter aortic valve replacement

Article Title: Coronary hemodynamic and plaque changes following transcatheter aortic valve replacement

Article References: Fang, Y., An, C., Sun, Y., Wang, B., Wang, G., Liang, Z., Li, Y., Xu, K., & Han, Y. (2026). Coronary hemodynamic and plaque changes following transcatheter aortic valve replacement. BMC Medical Imaging. https://doi.org/10.1186/s12880-026-02763-9

Image Credits: AI Generated

DOI: 10.1186/s12880-026-02763-9

Keywords: TAVR, aortic stenosis, CT-FFR, coronary CT angiography, fractional flow reserve, coronary plaque, left ventricular mass, reverse remodeling, cardiology, medical imaging, hemodynamics, BMC Medical Imaging